ALEXANDRIA, Va., July 15 -- United States Patent no. 12,664,657, issued on June 23, was assigned to Qureight Ltd. (Cambridge, Great Britain).

"Assessment of lung disease progression" was invented by Michael Thomas Roberts (Cambridge, Great Britain), Alessandro Ruggiero (Cambridge, Great Britain), Muhunthan Thillai (Cambridge, Great Britain) and Darren John Gallagher (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A machine learning approach is herein provided for preparing a model for assessing the progression of a lung disease, comprises receiving a first set of segmented images of lungs from different patients with the lung disease. The first set of images is segmented and used to ...